MEK MUTATION
Clinical trials for MEK MUTATION explained in plain language.
Never miss a new study
Get alerted when new MEK MUTATION trials appear
Sign up with your email to follow new studies for MEK MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Last-Resort cancer drug made available for patients with specific gene mutations
Disease control AVAILABLEThis program provides the experimental drug ulixertinib to people with advanced solid tumors that have certain gene mutations (MAPK pathway). It is for patients who have not responded well to or have run out of standard treatments. The goal is to control the disease and possibly …
Matched conditions: MEK MUTATION
Sponsor: xCures • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New pill targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests an experimental oral drug called NST-628 in adults with advanced solid tumors that have specific genetic changes in the MAPK pathway. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. About 230 partic…
Matched conditions: MEK MUTATION
Phase: PHASE1 • Sponsor: Nested Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC